Found: 11

Select item for more details and to access through your institution.

  • Multiplex Analysis of CircRNAs from Plasma Extracellular Vesicle-Enriched Samples for the Detection of Early-Stage Non-Small Cell Lung Cancer.

    Published in:
    Pharmaceutics, 2022, v. 14, n. 10, p. N.PAG, doi. 10.3390/pharmaceutics14102034
    By:
    • Pedraz-Valdunciel, Carlos;
    • Giannoukakos, Stavros;
    • Giménez-Capitán, Ana;
    • Fortunato, Diogo;
    • Filipska, Martyna;
    • Bertran-Alamillo, Jordi;
    • Bracht, Jillian W. P.;
    • Drozdowskyj, Ana;
    • Valarezo, Joselyn;
    • Zarovni, Natasa;
    • Fernández-Hilario, Alberto;
    • Hackenberg, Michael;
    • Aguilar-Hernández, Andrés;
    • Molina-Vila, Miguel Ángel;
    • Rosell, Rafael
    Publication type:
    Article

  • Author Correction: BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer.

    Published in:
    2023
    By:
    • Karachaliou, Niki;
    • Codony-Servat, Jordi;
    • Teixidó, Cristina;
    • Pilotto, Sara;
    • Drozdowskyj, Ana;
    • Codony-Servat, Carles;
    • Giménez-Capitán, Ana;
    • Molina-Vila, Miguel Angel;
    • Bertrán-Alamillo, Jordi;
    • Gervais, Radj;
    • Massuti, Bartomeu;
    • Morán, Teresa;
    • Majem, Margarita;
    • Felip, Enriqueta;
    • Carcereny, Enric;
    • García-Campelo, Rosario;
    • Viteri, Santiago;
    • González-Cao, María;
    • Morales-Espinosa, Daniela;
    • Verlicchi, Alberto
    Publication type:
    Product Review

  • Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial.

    Published in:
    Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26572-6
    By:
    • Gonzalez-Cao, Maria;
    • de las Casas, Clara Mayo;
    • Oramas, Juana;
    • Berciano-Guerrero, Miguel A.;
    • de la Cruz, Luis;
    • Cerezuela, Pablo;
    • Arance, Ana;
    • Muñoz-Couselo, Eva;
    • Espinosa, Enrique;
    • Puertolas, Teresa;
    • Beveridge, Roberto Diaz;
    • Ochenduszko, Sebastian;
    • Villanueva, Maria-Jose;
    • Basterretxea, Laura;
    • Bellido, Lorena;
    • Rodriguez, Delvys;
    • Campos, Begoña;
    • Montagut, Clara;
    • Drozdowskyj, Ana;
    • Molina, Miguel A.
    Publication type:
    Article

  • Cancer Stem Cell Biomarkers in EGFR-Mutation-Positive Non-Small-Cell Lung Cancer.

    Published in:
    2019
    By:
    • Codony-Servat, Jordi;
    • Codony-Servat, Carles;
    • Cardona, Andrés Felipe;
    • Giménez-Capitán, Ana;
    • Drozdowskyj, Ana;
    • Berenguer, Jordi;
    • Bracht, Jillian Wilhelmina Paulina;
    • Ito, Masaoki;
    • Karachaliou, Niki;
    • Rosell, Rafael
    Publication type:
    journal article

  • BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer.

    Published in:
    Scientific Reports, 2015, p. 17499, doi. 10.1038/srep17499
    By:
    • Karachaliou, Niki;
    • Codony-Servat, Jordi;
    • Teixidó, Cristina;
    • Pilotto, Sara;
    • Drozdowskyj, Ana;
    • Codony-Servat, Carles;
    • Giménez-Capitán, Ana;
    • Molina-Vila, Miguel Angel;
    • Bertrán-Alamillo, Jordi;
    • Gervais, Radj;
    • Massuti, Bartomeu;
    • Morán, Teresa;
    • Majem, Margarita;
    • Felip, Enriqueta;
    • Carcereny, Enric;
    • García-Campelo, Rosario;
    • Viteri, Santiago;
    • González-Cao, María;
    • Morales-Espinosa, Daniela;
    • Verlicchi, Alberto
    Publication type:
    Article

  • BRAF Mutations Classes I, II, and III in NSCLC Patients Included in the SLLIP Trial: The Need for a New Pre-Clinical Treatment Rationale.

    Published in:
    Cancers, 2019, v. 11, n. 9, p. 1381, doi. 10.3390/cancers11091381
    By:
    • Bracht, Jillian Wilhelmina Paulina;
    • Karachaliou, Niki;
    • Bivona, Trever;
    • Lanman, Richard B.;
    • Faull, Iris;
    • Nagy, Rebecca J.;
    • Drozdowskyj, Ana;
    • Berenguer, Jordi;
    • Fernandez-Bruno, Manuel;
    • Molina-Vila, Miguel Angel;
    • Rosell, Rafael
    Publication type:
    Article

  • Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients.

    Published in:
    Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758834017749748
    By:
    • Karachaliou, Niki;
    • Gonzalez-Cao, Maria;
    • Crespo, Guillermo;
    • Drozdowskyj, Ana;
    • Aldeguer, Erika;
    • Gimenez-Capitan, Ana;
    • Teixido, Cristina;
    • Molina-Vila, Miguel Angel;
    • Viteri, Santiago;
    • De Los Llanos Gil, Maria;
    • Algarra, Salvador Martin;
    • Perez-Ruiz, Elisabeth;
    • Marquez-Rodas, Ivan;
    • Rodriguez-Abreu, Delvys;
    • Blanco, Remedios;
    • Puertolas, Teresa;
    • Royo, Maria Angeles;
    • Rosell, Rafael
    Publication type:
    Article

  • Access to melanoma drugs in Spain: a cross-sectional survey.

    Published in:
    Clinical & Translational Oncology, 2024, v. 26, n. 10, p. 2572, doi. 10.1007/s12094-024-03501-9
    By:
    • Gonzalez-Cao, Maria;
    • Puertolas, Teresa;
    • Manzano, Jose Luis;
    • Maldonado, Cayetana;
    • Yelamos, Oriol;
    • Berciano-Guerrero, Miguel Ángel;
    • Cerezuela, Pablo;
    • Martin-Liberal, Juan;
    • Muñoz-Couselo, Eva;
    • Espinosa, Enrique;
    • Drozdowskyj, Ana;
    • Berrocal, Alfonso;
    • Soria, Ainara;
    • Marquez-Rodas, Ivan;
    • Martin-Algarra, Salvador;
    • Quindos, Maria;
    • Puig, Susana
    Publication type:
    Article

  • Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts.

    Published in:
    2018
    By:
    • Carbone, David;
    • Sharpnack, Michael;
    • He, Kai;
    • Butterfield, Lisa H.;
    • Eggermont, Alexander M. M.;
    • Gonzalez-Cao, Maria;
    • Karachaliou, Niki;
    • Crespo, Guillermo;
    • Aldeguer, Erika;
    • Drozdowskyj, Ana;
    • Giménez-Capitán, Ana;
    • Teixidó, Cristina;
    • Molina-Vila, Miguel Angel;
    • Ramírez, Santiago Viteri;
    • Algarra, Salvador Martin;
    • Pérez-Ruiz, Elisabeth;
    • Márquez-Rodas, Iván;
    • Rodriguez-Abreu, Delvys;
    • Blanco, Remei;
    • Puértolas, Teresa
    Publication type:
    Abstract

  • Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer.

    Published in:
    Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-00450-6
    By:
    • Jacobsen, Kirstine;
    • Bertran-Alamillo, Jordi;
    • Molina, Miguel Angel;
    • Teixidó, Cristina;
    • Karachaliou, Niki;
    • Pedersen, Martin Haar;
    • Castellví, Josep;
    • Garzón, Mónica;
    • Codony-Servat, Carles;
    • Codony-Servat, Jordi;
    • Giménez-Capitán, Ana;
    • Drozdowskyj, Ana;
    • Viteri, Santiago;
    • Larsen, Martin R.;
    • Lassen, Ulrik;
    • Felip, Enriqueta;
    • Bivona, Trever G.;
    • Ditzel, Henrik J.;
    • Rosell, Rafael
    Publication type:
    Article

  • Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC.

    Published in:
    2017
    By:
    • Chaib, Imane;
    • Karachaliou, Niki;
    • Pilotto, Sara;
    • Servat, Jordi Codony;
    • Xueting Cai;
    • Xuefei Li;
    • Drozdowskyj, Ana;
    • Servat, Carles Codony;
    • Jie Yang;
    • Chunping Hu;
    • Cardona, Andres Felipe;
    • Vivanco, Guillermo Lopez;
    • Vergnenegre, Alain;
    • Sanchez, Jose Miguel;
    • Provencio, Mariano;
    • Reguart, Noemi;
    • Caicun Zhou;
    • Peng Cao;
    • Ma, Patrick C.;
    • Bivona, Trever G.
    Publication type:
    journal article